Direct Access to MRI and Neurology Referrals for the Management of Patients With Chronic Headache.
An Observational Study to Evaluate Referral From General Practitioners (GPs) to: 1) Direct Access to Magnetic Resonance Imaging (MRI); and 2) the Neurology Department for the Management of Patients With Chronic Headache.
1 other identifier
observational
296
1 country
1
Brief Summary
This study aims to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache decreases overall NHS costs and increases patient satisfaction compared to clinical practice with referral to Neurology Services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 25, 2016
CompletedFirst Posted
Study publicly available on registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedAugust 8, 2017
August 1, 2017
2.2 years
April 25, 2016
August 7, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
6-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient)
The primary objective is to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is associated with cost-savings at 6 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department.
6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Secondary Outcomes (8)
12-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient)
12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
6-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY)
6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
12-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY)
12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Patient satisfaction associated with both clinical pathways (direct referral to MRI or Neurology)
6 months
Patient's self perceived quality of life - measured using EQ-5D-5L questionnaire
6 months
- +3 more secondary outcomes
Study Arms (2)
MRI scan
Direct referral from Primary Care (GPs) to an MRI scan as the initial Secondary Care point of contact.
Neurology Appointment
Referral from Primary Care (GPs) to Neurology Services in Secondary Care as the initial Secondary Care point of contact.
Interventions
Outpatient appointment with Neurologist as the first Secondary Care contact
Eligibility Criteria
Patients with chronic headache referred from Primary Care to Secondary Care to either an MRI scan or a Neurology outpatient appointment.
You may qualify if:
- Every patient aged 16 years or over with: i) chronic headache as a primary cause that has lasted ≥ 15 days per month for more than 3 months; and ii) referred from GP practices to GSTT, either directly referred to an MRI exam or a Neurology outpatient appointment.
You may not qualify if:
- Children under the age of 16;
- Patients with red flags as defined in NICE guideline CG150;
- Patients without chronic primary headache, i.e. a headache that has not persisted for ≥ 15 days per month for more than 3 months
- Patients with headache referred through the two week wait list;
- Patients who lack capacity to give consent or participate in the study;
- Patients not fluent in English;
- Prisoners;
- Patients that are already taking part in a clinical trial of an investigational medicinal products (CTIMPs).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guy's and St Thomas' NHS Foundation Trustlead
- King's College Londoncollaborator
Study Sites (1)
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH, United Kingdom
Related Publications (1)
Rua T, Mazumder A, Akande Y, Margariti C, Ochulor J, Turville J, Razavi R, Peacock JL, McCrone P, Goh V, Shearer J, Afridi S. Management of chronic headache with referral from primary care to direct access to MRI compared with Neurology services: an observational prospective study in London. BMJ Open. 2020 Oct 16;10(10):e036097. doi: 10.1136/bmjopen-2019-036097.
PMID: 33067273DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asif Mazumder, MD
Guy's and St Thomas' NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2016
First Posted
April 28, 2016
Study Start
April 1, 2016
Primary Completion
June 1, 2018
Study Completion
December 1, 2018
Last Updated
August 8, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share